Cargando…
Blockade of JAK2 protects mice against hypoxia‐induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation
OBJECTIVES: Hypoxia is an important risk factor for pulmonary arterial remodelling in pulmonary arterial hypertension (PAH), and the Janus kinase 2 (JAK2) is believed to be involved in this process. In the present report, we aimed to investigate the role of JAK2 in vascular smooth muscle cells durin...
Autores principales: | Zhang, Lei, Wang, Yi, Wu, Guorao, Rao, Lizong, Wei, Yanqiu, Yue, Huihui, Yuan, Ting, Yang, Ping, Xiong, Fei, Zhang, Shu, Zhou, Qing, Chen, Zhishui, Li, Jinxiu, Mo, Bi‐Wen, Zhang, Huilan, Xiong, Weining, Wang, Cong‐Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046303/ https://www.ncbi.nlm.nih.gov/pubmed/31943454 http://dx.doi.org/10.1111/cpr.12742 |
Ejemplares similares
-
Macrophages: friend or foe in idiopathic pulmonary fibrosis?
por: Zhang, Lei, et al.
Publicado: (2018) -
Endogenous Estrogen Attenuates Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Vasoconstriction and Pulmonary Arterial Smooth Muscle Cells Proliferation
por: Xu, Dunquan, et al.
Publicado: (2013) -
Effect of thoracic epidural blockade on hypoxia-induced pulmonary arterial hypertension in rats
por: YU, Shi-huan, et al.
Publicado: (2014) -
Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis
por: Pan, Ting, et al.
Publicado: (2021) -
Nocturnal hypoxia in patients with idiopathic pulmonary arterial
hypertension
por: Yan, Lu, et al.
Publicado: (2020)